BIIB vs OLB · P/E 21, rev $9.89B vs rev $1.3M
Biogen Inc (BIIB) versus OLB Group Inc (OLB) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
OLB Group Inc (OLB) is a software - infrastructure company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported OLB revenue for 2026-06-30 was $1.3M. Net income was -$1.1M. Revenue was down 22.8% from 2026-03-31 to 2026-06-30. OLB currently screens at market cap $5.1M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. OLB currently screens at market cap $5.1M.
Not investment advice. Open the BIIB and OLB stock pages for the full models.
Not investment advice.